In quest to elim­i­nate trop­i­cal dis­eases, Mer­ck KGaA will sub­mit an­ti-worm­ing drug for ap­proval in young chil­dren

As Mer­ck KGaA makes moves to treat the ne­glect­ed trop­i­cal dis­ease schis­to­so­mi­a­sis, it has an­nounced that its treat­ment arpraz­i­quan­tel has yield­ed pos­i­tive Phase III tri­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER